Premedication with erythromycin improves endoscopic visualization of the gastric mucosa in patients with subtotal gastrectomy: a prospective, randomized, controlled trial
- 1 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 28 (5), 1641-1647
- https://doi.org/10.1007/s00464-013-3364-y
Abstract
Food residue in the remnant stomach after subtotal gastrectomy (STG) interferes with endoscopic observation. We investigated whether intravenous erythromycin improves gastric mucosa visualization in patients with STG. This study was conducted from April 2012 to October 2012 as a double-blinded, placebo-controlled, randomized trial. Patients who received STG with complete resection (stage T1–2N0M0) were included. Exclusion criteria were diabetes mellitus, neurologic disease, myopathy, recent viral enteritis history, concomitant therapy influencing gastrointestinal motility and severe comorbidity. Patients were instructed to consume a soft diet for dinner between 1800 and 2000 h, and endoscopies were performed between 0900 and 1200 h. Patients were assigned randomly to receive either erythromycin (125 mg in normal saline 50 cc) or placebo saline. The endoscopy was performed 15 min after infusion. Grade of residual food was rated as follows: G0, no residual food; G1, a small amount of residual food; G2, a moderate amount of residual food; G3, a moderate amount of residual food that hinders observation of the entire surface, even with body rolling; G4, a great amount of residual food such that endoscopic observation is impossible. When good visibility was defined as G0+G1, visibility was significantly better in the erythromycin group (61 + 19 %) than in the placebo group (38 + 12 %, p n = 58) was food stasis at last endoscopy. The only factor predicting erythromycin response in the erythromycin group (n = 56) was elapsed time since surgery. Adverse effects included nausea [11 (19.7 %)] and vomiting [1 (1.8 %)] in the erythromycin group and vomiting [3 (5.2 %)] in the placebo group. However, they were transient and tolerable. Premedication with erythromycin improves mucosal visualization during endoscopy in patients with STG. (Clinical Trials registration number: NCT01659619).Keywords
This publication has 24 references indexed in Scilit:
- Proper preparation to reduce endoscopic reexamination due to food residue after distal gastrectomy for gastric cancerSurgical Endoscopy, 2012
- Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomyWorld Journal of Gastroenterology, 2012
- Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trialGastrointestinal Endoscopy, 2011
- Risk Factors for Food Residue after Distal Gastrectomy and a New Effective Preparation for Endoscopy: The Water-Intake MethodGut and Liver, 2009
- The influence of reconstruction methods on food retention phenomenon in the remnant stomach after a subtotal gastrectomyJournal of Surgical Oncology, 2008
- Food Residue at Endoscopy in Patients Who Have Previously Undergone Distal Gastrectomy: Risk Factors and Patient PreparationEndoscopy, 2003
- Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classificationGastric Cancer, 2002
- Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesisDigestive Diseases and Sciences, 1995
- Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomyDigestive Diseases and Sciences, 1994
- Erythromycin accelerates solid emptying at the expense of gastric sievingDigestive Diseases and Sciences, 1994